We are live on
!
Find out more
AI
Alphabet Inc Portfolio holdings
AUM
$4.02B
1-Year Est. Return
215.74%
This Fund
S&P 500
1 Year Est. Return
+215.74%
AUM
$2.58B
AUM Growth
+$171M
(+7.1%)
Holding
37
Top Buys
No buys this quarter
Top Sells
| 1 | +$198M | |
| 2 | +$51.7M | |
| 3 | +$35.2M | |
| 4 |
Monte Rosa Therapeutics
GLUE
|
+$9.69M |
| 5 |
Dianthus Therapeutics
DNTH
|
+$8.21M |
Sector Composition
| 1 | Technology | 49.93% |
| 2 | Healthcare | 25.65% |
| 3 | Industrials | 24.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tenaya Therapeutics
TNYA
$156M
| $650K | 0.03% |
915,705
|
|
||
27
Quince Therapeutics
QNCX
$18.5M
| $634K | 0.02% |
18,912
|
|
||
28
Fulcrum Therapeutics
FULC
$253M
| $161K | 0.01% |
14,262
|
|
||
29
Repligen
RGEN
$8.29B
| $62.8K | ﹤0.01% |
383
|
|
||
30
Alector
ALEC
$207M
| – | – |
-175,866
|
|
||
|
BRNS
31
Barinthus Biotherapeutics
BRNS
$28.6M
| – | – |
-1,513,644
|
|
||
|
32
Dianthus Therapeutics
DNTH
$5.21B
| – | – |
-208,697
|
|
||
33
Foghorn Therapeutics
FHTX
$248M
| – | – |
-500,901
|
|
||
34
TScan Therapeutics
TCRX
$63.3M
| – | – |
-1,077,080
|
|
||
35
Taysha Gene Therapies
TSHA
$1.82B
| – | – |
-640,882
|
|
||
36
Fractyl Health
GUTS
$118M
| – | – |
-662,584
|
|
||
|
MTSR
37
DELISTED
Metsera Inc
MTSR
| – | – |
-3,783,528
|
|